7L9Y image
Deposition Date 2021-01-05
Release Date 2021-04-21
Last Version Date 2024-11-06
Entry Detail
PDB ID:
7L9Y
Title:
Human PARP14 (ARTD8), catalytic fragment in complex with RBN012042
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.25 Å
R-Value Free:
0.29
R-Value Work:
0.26
R-Value Observed:
0.26
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Protein mono-ADP-ribosyltransferase PARP14
Gene (Uniprot):PARP14
Chain IDs:A, B, C, D
Chain Length:194
Number of Molecules:4
Biological Source:Homo sapiens
Primary Citation
Targeted Degradation of PARP14 Using a Heterobifunctional Small Molecule.
Chembiochem 22 2107 2110 (2021)
PMID: 33838082 DOI: 10.1002/cbic.202100047

Abstact

PARP14 is an interferon-stimulated gene that is overexpressed in multiple tumor types, influencing pro-tumor macrophage polarization as well as suppressing the antitumor inflammation response by modulating IFN-γ and IL-4 signaling. PARP14 is a 203 kDa protein that possesses a catalytic domain responsible for the transfer of mono-ADP-ribose to its substrates. PARP14 also contains three macrodomains and a WWE domain which are binding modules for mono-ADP-ribose and poly-ADP-ribose, respectively, in addition to two RNA recognition motifs. Catalytic inhibitors of PARP14 have been shown to reverse IL-4 driven pro-tumor gene expression in macrophages, however it is not clear what roles the non-enzymatic biomolecular recognition motifs play in PARP14-driven immunology and inflammation. To further understand this, we have discovered a heterobifunctional small molecule designed based on a catalytic inhibitor of PARP14 that binds in the enzyme's NAD+ -binding site and recruits cereblon to ubiquitinate it and selectively target it for degradation.

Legend

Protein

Chemical

Disease

Primary Citation of related structures